SBRT prostate after prior EBRT?

This forum made possible through the generous support of SDN members, donors, and sponsors. Thank you.

thesauce

Senior Member
15+ Year Member
Joined
Aug 5, 2005
Messages
3,664
Reaction score
1,198
Has anyone done SBRT after prior EBRT or brachy? I found 2 relatively recent studies and it seems to be equally-effective and better tolerated than some other modalities out there. Thoughts?



Members don't see this ad.
 
  • Like
Reactions: 1 users
I do it all the time. I use Dr. Fuller's protocol published in PRO.

 
  • Like
Reactions: 2 users
Has anyone done SBRT after prior EBRT or brachy? I found 2 relatively recent studies and it seems to be equally-effective and better tolerated than some other modalities out there. Thoughts?


Unless they have had prior LDR brachy, I typically prefer HDR for in-gland salvage. There is a pretty good literature for it. I have yet to see a major complication or even severe LUTs. The literature on salvage SBRT is mixed but I know folks (apparently GFunk is one of them) who do it and it seems to go ok as well.
 
Members don't see this ad :)
Yes, our practice does. I personally have not done it for in-gland recurrences less than 4 years after previous EBRT. I do try to get a perirectal spacer in before re-RT, but optimal spacer placement is not as high as in the RT-naive setting given fibrosis/scarring in that space. It does take a fair amount more dissection and gentle manipulation to create the pocket. We've used 35-36.25/5fx.
 
I've done it after HDR which was done more than 10 years ago. It was scary to do, but the patient has done well.
 
I haven't done this.

Excuse my ignorance.

Do you all do just focal radiation based upon biopsy location/MRI (and now PSMA or axumin)? LIke gross disease plus (small) margin?

Of note, on quick glance at the Fuller paper they only included patients with G1 toxicity at XRT round 1 only. So clearly you need to be selective.
 
I treat whole gland but dose escalate to gross disease

I think that's what I would probably do too in my theoretical world.

But a congruent saturation biopsy, MRI, and now with PSMA pet would be really tempting to just treat a hot area.
 
I think that's what I would probably do too in my theoretical world.

But a congruent saturation biopsy, MRI, and now with PSMA pet would be really tempting to just treat a hot area.
I see where you are coming from but the counter argument is you only get one shot at this. I’ve re-treated the whole gland with HDR 30/3 (albeit in folks with good baseline urinary function) a few times without any notable toxicity. In the definitive setting, hemi-gland BT failed miserably even with pretty thorough work up. Until I see good data otherwise, I feel like if you are going to do it, do it right.
 
  • Like
Reactions: 1 users
36.25 / 5 fractions; checking every day that no hot spot in urethra (max dose 38.8) as well as the prostate/rectal boundary is appropriate. Some patients have had fluciclovine PET, only a few with PSMA-PET due to availability where we are. We may have done between 5 and 10 cases thus far. Since we have MR guidance, we have been using that. Not enough for a series yet.
 
On a slightly different but related note, I have also used 45/30 BID as an aggressive palliation dose for folks with symptomatic in gland recurrences after full dose in guys who also have Mets and been extremely happy with it. First guy I did it in was close to needing a suprapubic cath. Told him I might make things better or worse and ended up getting him 2.5 years of complete resolution of his LUTS. Oddly enough, it helped with his castrate resistance too. I eventually ended up treating his PA nodes with a modest dose and he’s still doing great on ADT (though PSA is starting to rise slowly again even on ADT…but still, happy to buy a couple more years). No toxicity issues. I’ve also used this dose a couple times for secondary rectal cancers after bladder or prostate RT in medically inoperable folks a few times. Not enough for a series but something that has served me well.
 
  • Like
Reactions: 2 users
36.25 / 5 fractions; checking every day that no hot spot in urethra (max dose 38.8) as well as the prostate/rectal boundary is appropriate. Some patients have had fluciclovine PET, only a few with PSMA-PET due to availability where we are. We may have done between 5 and 10 cases thus far. Since we have MR guidance, we have been using that. Not enough for a series yet.

Putting spacer in?
 
Not sure if prior radiation affects denonvilliers fascia? Edit: just checked it seems to be a relative contraindication
I just put in a SpaceOAR on a patient with locally recurrent prostate cancer s/p IMRT (78 Gy) delivered about 7 years ago. Axumin PET confirmed local recurrence without regional or metastatic disease.

Both the prostate and denonvilliers fascia were notably fibrotic based on the tactile feel with the needles. However, the fascia in particular appeared normal (like fat) on TRUS.
 
  • Like
Reactions: 1 users
Putting spacer in?
Yes, definitely try to place SpaceOAR. I have performed a few and I will usually encounter some fibrosis of the Denonvilliers Fascia. Most will open up with hydrodissection to allow adequate placement of the gel, but some are totally stuck. It those situations, I may decide to go partial prostate vs whole gland, depending on disease location/size and pt's baseline GI/urinary status. Salvage brachy, HIFU, Cryo can be considered if you have the expertise locally...
 
  • Like
Reactions: 2 users
Top